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Abstract 
Background 
Both helminth and malaria infections result in a highly polarized immune response 
characterized by IgE production. This study aimed to investigate the total serum IgE profile 
in vivo as a measure of Th2 immune response in malaria patients with and without helminth 
co-infection. 
Methods 
A cross sectional observational study composed of microscopically confirmed malaria 
positive (N = 197) and malaria negative (N = 216) apparently healthy controls with and 
without helminth infection was conducted at Wondo Genet Health Center, Southern Ethiopia. 
A pre-designed structured format was utilized to collect socio-demographic and clinical data 
of the subjects. Detection and quantification of helminths, malaria parasites and 
determination of serum IgE levels were carried out following standard procedures. 
Results 
Irrespective of helminth infection, individuals infected by malaria showed significantly high 
levels of serum IgE compared with malaria free apparently healthy controls (with and without 
helminth infections). Moreover, malaria patients co-infected with intestinal helminths showed 
high level of serum IgE compared with those malaria patients without intestinal helminths 
(2198 IU/ml versus1668 IU/ml). A strong statistically significant association was observed 
between malaria parasite density and elevated serum IgE levels (2047 IU/ml versus 1778 
IU/ml; P = 0.001) with high and low parasitaemia (parasite density >50,000 parasite/µl of 
blood), respectively. Likewise, helminth egg loads are significantly associated with elevated 
serum IgE levels (P = 0.003). 
Conclusions 
The elevated serum IgE response in malaria patients irrespective of helminth infection and its 
correlation with malaria parasite density and helminth egg intensity support that malaria 
infection is also a strong driver of IgE production as compared to helminths. 
Keywords 
Helminths, Malaria, Th2, IgE, Ethiopia 
Background 
Malaria remains one of the major causes of morbidity and mortality in the developing world 
and about 70% of the cases and 90% deaths are from Africa [1,2]. Similarly, helminthic 
infections are widely distributed in tropical and sub tropical areas of the developing countries. 
Helminthic infections are estimated to cause one million deaths per year and affect the health 
status of an individual on its physical, mental development and cause malnutrition, anaemia, 
stunted growth, cognitive impairment and lowered educational achievement [3]. Concurrent 
infection with helminths has been recognized as a possible confounding factor modulating the 
immune response to other pathogens [4,5]. Chronic helminthic infection results in a highly 
polarized immune response characterized by elevated T-helper cell type 2 cytokine, IgE 
production, eosinophilia [6] and are associated with increased immunological reactivity [5-8]. 
In sub Saharan Africa, due to the high prevalence of helminthic infections, a dominant Th2 
immune response has been suggested to increase susceptibility to malaria, M. tuberculosis 
and HIV [9] and to hasten progression of these diseases [6,10,11]. Such an imbalance with an 
increase in Th2 cells favors IgE production [12], which may influence the clinical features of 
the disease. The immunological reports on interactions between malaria and helminths are 
still controversial. For example, the observation of high anti-P. falciparum IgE levels with a 
reduced risk of developing clinical malaria suggests the involvement of IgE in protection 
[13,14]. In contrast, the observation that circulating levels of IgE often correlate with severe 
rather than uncomplicated malaria suggests a pathogenic role of IgE [15,16]. A recent study 
from malaria endemic areas of Gabon and India showed that circulating levels of total IgE do 
not appear to correlate with protection or pathology of malaria [17]. 
In Ethiopia, malaria has been consistently reported as one of the three leading causes of 
morbidity and mortality in the past years, although a declining trend has been observed in 
recent years [18]. Like other developing countries Ethiopia is also endemic for helminthic 
infections [19-24]. We and others have reported malaria-helminth co-infecton rates and the 
possible impact of helminthes infection on prevalence and clinical outcomes of malaria [24-
26] and the impact of deworming [25,27,28]. However, data on the relationship of the host 
immune response correlates during malaria-helminths co-infection are lacking. Thus 
understanding the immune response during malaria-helminth co-infection will maximize the 
probability of identifying new targets for the design and development of immunotherapeutic 
approaches and the prevention and control of both infections in highly endemic areas. This 
study was conducted to investigate the IgE profile in vivo, as a measure of the Th2 immune 
response, among malaria patients with and without helminth co-infection from south Ethiopia 
where the epidemiological coexistence of these infections is very high. 
Methods 
This cross sectional observational study was conducted at Wondo Genet Health Center, 
Southern Ethiopia in 2006/2007. The inclusion criteria of the study subjects and the settings 
were briefly described earlier [25]. However, in this study adult patients who were 
microscopically positive for malaria (N = 197) with an age range of 20–49 years old were 
only included. Apparently healthy individuals upon physical examination, free from signs 
and symptoms of acute febrile illness for the last two weeks from the same endemic locale (N 
= 169) and from malaria non-endemic Ethiopian highlands (N = 47) were also used as 
controls. All the healthy controls were microscopically negative for Plasmodium species and 
all the subjects were naïve for anthelminthic or anti-malarial drugs for four weeks time prior 
to data collection. 
A pre-designed structured format was used to collect socio-demographic and all relevant 
clinical data of the patients. After getting written and /or verbal informed consent, 5 ml of 
venous blood was collected in vacutainer tubes. Then when the clot had retracted serum was 
separated and stored at −20°C until used for measurement of serum. 
Both thick and thin blood films were made in a single slide and were stained with Giemsa’s 
staining solution for detection and quantification of malaria parasites [MOH, Standard 
Malaria Diagnosis and Treatment Guideline, 2004]. To detect malaria infections, 200 fields 
(the equivalent of 0.5 µl of thick blood film) were examined as described before [25]. Briefly, 
the parasite density was expressed per micro liter [µl] of blood assuming 8000 leucocytes per 
µl of blood. In brief, a thick film was selected where the white blood cells were evenly 
distributed. Using the oil immersion objective, 200 white blood cells were counted 
systematically, by counting at the same time the number of parasites (asexual form only) in 
each field was covered. Then, the number of parasite per µl of blood was calculated by 
multiplying the number of parasite (asexual stages) counted against 200 leucocytes and 8000 
leucocytes and dividing the product by 200 [29]. 
The presence of intestinal parasites was detected from stool samples using direct microscopy 
and formol-ether sedimentation techniques. Moreover, coarse quantification of eggs was 
obtained by counting the number of eggs on a smear of 41.7 mg of feces, and a quantitative 
variable scoring (light infection/ low worm burden, moderate infection/ medium worm 
burden and heavy infection/ massive worm burden) was created for each helminth following 
the standard procedure used by WHO [29,30]. 
The total serum IgE levels were quantified by total IgE ELISA kit (IBL Immunobiological 
Laboratories, Hamburg, Germany) following the manufacturer’s instructions as described 
earlier [25]. Briefly, 10 ml serum samples or standard IgE were pipetted in duplicate into 
wells of microtiter plates precoated with monoclonal mouse antihuman IgE antibody together 
with per-oxidase conjugated antihuman IgE. After incubation for 30 min at room temperature 
the plates were rinsed with diluted wash buffer to remove unbound material. Then a substrate 
solution (tetra methyl benzidine) was pipetted and incubated for 15 minutes to induce 
development of color. The reaction was terminated by the addition of stop solution and the 
resulting dye was measured in a spectrophotometer at a wave length of 450 nm against the 
substrate blank. The IgE concentration of the samples was read from a standard curve. Mean 
values of two separate determinations from each sample were used as serum IgE levels of a 
particular study subject. This was only done on 89 randomly selected malaria patients (20–49 
years) with (n = 28) and without (n = 28) helminth co-infection; and malaria negative 
apparently healthy controls with (n = 20) and without (n = 20) helminth co-infection from 
malaria endemic areas and without helminth (n = 9) from malaria non endemic areas. 
Subjects found positive for intestinal protozoa (Entamoeba histolytica and Giardia lamblia) 
were not included for IgE determination. This is because of different IgE responses observed 
in protozoal and helminths infections. 
The data was analyzed using to SPSS version 15 statistical package software. Intestinal 
parasite densities were transformed to log for analysis and geometric mean was used. Non-
parametric tests were performed to compare mean values of the different groups. The Mann 
Whitney test and the Kruskall Wallis tests were used for comparisons between two groups 
and three or more groups, respectively. Spearman’s correlation was used to check for 
correlations between parameters. P values were considered significant when found <0.05. 
The study protocol and design including the consent procedures were approved by The 
Ethical Review Committee of the Aklilu Lemma Institute of Pathobiology, Addis Ababa 
University and South Nations and Nationalities Peoples Region Health Department. Written 
(from those who can read and write) or verbal (from those who can’t read and write) 
informed consent from all study subjects was also obtained. The written informed consent 
and the ethical clearance letters are documented in both offices. However, verbal consent was 
not recorded and documented. The consent procedures were also approved by both The 
Ethical Review Committee of the Aklilu Lemma Institute of Pathobiology, Addis Ababa 
University and South Nations and Nationalities Peoples Region Health Department. Patients 
with malaria and helminthiasis were managed as part of the routine clinical management of 
patients in the health care facilities following the national guideline [MOH, Standard 
Treatment Guidelines, 2004]. 
Results 
In this cross sectional observational study 197 malaria patients and 216 malaria free 
apparently healthy controls were included. The mean age of the study subjects in both groups 
was not different (34 versus 35 years). The male female ration was also 1: 1.2. The 
demographic characteristics of the pateints, magnitude of malaria and type and destitution of 
helminthes were described previously [25]. Fifty six percent of the malaria infections were 
due P. falciparum. Plasmodium vivax accounted for 35.2% of malaria cases. Mixed infections 
with P. falciparum and P. vivax were detected in 6% of the subjects. Irrespective of malaria 
infection, high rates of helminth infection were observed in the settings. There was no 
significant difference in magnitude of helminths among malaria patients and malaria free 
apparently healthy controls (78.2% (154/197) versus 84.3% (182/216)), respectively. The 
pattern of helminth infection in malaria positive and malaria free apparently healthy controls 
was similar (Table 1). The most frequent intestinal helminths detected were Trichuris 
trichiura, Ascaris lumbricoides, Schistosoma mansoni and hookworm. A small proportion of 
the patients were also infected with intestinal protozoan cysts of Giardia lamblia (2 patients) 
and Entamoeba histolytica/dispar (5 patients). The least encountered helminths were Taenia 
species (7), and Strongyloides stercoralis (2). Twenty-three percent of the subjects from both 
groups had a single infection. Multiple infection i.e. infection with 2, 3 and 4 different 
species of intestinal parasites were observed in 37.0% (132/356), 21.6% (77/356) and 3.4% 
(12/356) patients, respectively. The frequent combinations of helminths diagnosed in single 
patients were A. lumbricoides - T. trichiura in 28.8%; A. lumbricoides - T. trichiura - S. 
mansoni in 18.5%, and A. lumbricoides -T trichiura- Hookworm in 8% of the patients. In 4% 
of the patients 4 different helminths: A. lumbricoides, T. trichiura, S. mansoni and hookworm 
were observed. 
  
Table 1 Magnitude of intestinal helminthsa in malaria patients and malaria free 
apparently healthy controls (numbers given in brackets percentages) 
Type of helminths Malaria No malaria¶ Total¶ OR P† 
(N = 197) (N = 216) (N = 413) (95% CI) # 
T. trichura 119 (63.6) 98(58.0) 217(61.0) 1.361(1.119,1.655) 0.002 
A. lumbricoides 98(52.4) 98(58.0) 196(55.1) 1.147 (0.780,1.687) 1.147 
S. mansoni 52(27.8) 43(25.4) 95(26.7) 1.137 (0.976,1.326) 1.137 
Hookworm 23(12.3) 19(11.2) 42(11.8) 1.086 (0.926,1.275) 1.086 
a: because of multiple infection the total is not summed up to 100; ¶ = coefficient of regression; OR = 
Odds ratio; #CI = Confidence interval; † = P value. 
Although, it is very difficult to have a normal range of IgE even at a population level, a range 
of values of IgE levels was defined enabling the analysis of the frequency of normal, 
moderate and high IgE levels in each group of patients. Normal values were adjusted because 
the groups had a wide range of different total serum IgE level. Thus, the normal value (N) 
was defined by the median IgE levels from malaria free apparently healthy helminth negative 
controls from malaria non endemic area. Accordingly, serum IgE values between N and 1.5 
N were considered as low, between 1.5 N and 2 N as moderate IgE levels and above 2 N as 
the highest levels. 
As indicated in Figure 1, irrespective of helminth infection, individuals infected by malaria 
showed significantly high levels of serum IgE compared with malaria free apparently healthy 
controls (with and without helminth infections). Moreover, malaria patients co-infected with 
intestinal helminths showed high levels of serum IgE compared with those malaria patients 
without intestinal helminths (2198 IU/ml versus1668 IU/ml). There was no statistically 
significant (P > 0.05) difference in mean serum concentrations of IgE between falciparum 
and vivax malaria (2165 IU/ml versus 1978 IU/ml; P = 0.063) irrespective of helminth co-
infection. However, a strong statistically significant association was observed between 
malaria parasite density and elevated serum IgE level (2047 IU/ml versus 1778 IU/ml; P = 
0.001) for high and low parasitaemia (parasite density >50,000 parasite/µl of blood), 
respectively. Likewise, significant association (P = 0.003) was found between helminth egg 
load and serum IgE levels in both malaria positive and malaria free apparently healthy 
controls with helminth infection after controlling for malaria infection (Figure 2). No 
significant association was found between presence of individual intestinal parasites and 
serum IgE level (P = 0.089). Individuals with helminth-helminth coinfection had slightly 
higher mean serum IgE levels than those infected with single parasites (1894 IU/ml vs.1654 
IU/ml). In both groups levels of serum IgE was not correlated with age and gender 
differences (P = 0.45). 
Figure 1 Mean serum IgE levels in adult malaria patients with and without helminths 
infection and malaria free health controls without and with out helminths coinfections. 
EA: malaria endemic area; NEA: malaria non-endemic area 
Figure 2 Correlation between helminthic load and serum IgE level helminths and 
malaria infected individuals. 
Discussion 
The finding of elevated serum IgE level among malaria patients irrespective of helminth co-
infection and the high serum IgE concentration in malaria free helminth infected apparently 
healthly controls is in agreement with previous studies [17,31,32] and supports the data that 
both malaria and helminth infection shifts the immune response to Th2 type. Interestingly, 
this study is the first in its kind to report the association between malaria parasite density and 
helminth egg intensity with elevated serum IgE level. The highly elevated serum IgE level in 
malaria infected patients with helminth co-infection in the current study might be a result of 
both malaria and helminth induced immune dysregulation which induces a shift in cytokine 
production from Th1 to Th2 [32] and the resulting polyclonal activation of B cells in which 
the production of cytokines (including IL-4 and IL-6) from Th2 cells increases synthesis of 
IgE. Further more the higher IgE levels in malaria free apparently healthy controls without 
helminth infection from both malaria endemic and non endemic areas may be due to 
environmental factors and genetic background, which may predispose to the development of 
IgE [33]. Although, a significant increase in IgE levels with age was reported from other 
malaria endemic African countries [33], which may be a reflection of an increase in the 
capacity of the immune system to respond to parasite infections, we do not observe such 
correlation. This would be expected because the study groups in the current study comprised 
exclusively adults ranging from 20–49 years old. 
The correlation of malaria parasite density and helminth egg intensity with elevated serum 
IgE levels could also contribute to severity of disease. As it was reported [15,16], total IgE 
elevation has been described as a pathogenic factor during malaria. In support of this we have 
also observed significantly high serum IgE levels with parasite density >50,000 parasite/µl of 
blood. However, serum IgE level was not different in different clinical forms of malaria 
(uncomplicated, severe and cerebral malaria) unlike previous report from Gabon and India 
[17]. This could be the hyper endemicity of malaria in the present study group which suggests 
that exposure to the parasite strongly influences the production of IgE, although this 
difference may also be due to other factors as well. Nevertheless, it was reported that IgE 
levels were higher in patients with severe malaria infection. Although, total IgE level 
increased in helminth infection, it usually does not eliminate worms [32]. Moreover, 
evolution seemed to have selective antigenic determinants with potent IgE-inducing 
capabilities. For example Ascaris is highly allergenic; if the function of IgE was only to get 
rid of worms; it would seem detrimental for Ascaris to induce it. However, no significant 
association was found between presence of individual helminths and serum IgE levels in the 
current study. The prevalence of intestinal parasites among malaria patients and malaria free 
apparently health individuals were as high, which corresponds well with previous studies 
from Ethiopia [22-25] and shows the endemicity of helminthiasis in the area. We and others 
have previously reported elevated IgE levels from untreated TB-HIV co-infected patients 
with and without helminth co-infection indicating an in vivo evidence for Th2 activation 
[32,34-36]. Thus the findings of the current study are also additional evidence for the change 
in the immune system during malaria and heleminth concurrent infection towards T helper −2 
dominant types. 
Conclusions 
Despite the low sample size and the cross-sectional nature of the study, a remarkably elevated 
total serum IgE level in malaria patients irrespective of helminth co-infection was observed. 
The elevated serum IgE response in malaria patients irrespective of helminth infection and its 
correlation with malaria parasite density and helminth egg intensity support that malaria 
infection is a strong driver of IgE production as helminth. Thus, mass deworming may be a 
cost effective approach in reducing the morbidity of helminths and co-infection where 
malaria, tuberculosis and HIV are endemic. 
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